BM
ACOR

Bridger Management’s Acorda Therapeutics ACOR Stock Holding History

Bridger Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-5,927
Closed -$29.1M – 42
2014
Q4 		$29.1M Buy
5,927
+456
+8% +$1.96M 1.83% 24
2014
Q3 		$22.2M Sell
5,471
-3,862
-41% -$14.5M 1.52% 30
2014
Q2 		$37.8M Buy
+9,333
New +$38.1M 2.66% 21

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Bridger Management's ACOR Position: Q1 2015 in Review

Bridger Management sold out of Acorda Therapeutics (ACOR) in Q1 2015, closing a stake of 5,927 shares — an estimated $29.1M sold.

Bridger Management first reported a position in ACOR in Q2 2014 and held it in 3 quarters. The position peaked at $37.8M in Q2 2014. 190 funds tracked by Wall St. Rank hold ACOR as of Q1 2015.

  • Bridger Management reported no remaining Acorda Therapeutics position as of Q1 2015 after selling out during the quarter.
  • Bridger Management sold 5,927 Acorda Therapeutics shares in Q1 2015, an estimated $29.1M.
  • Bridger Management first reported a position in Acorda Therapeutics in Q2 2014 and held it in 3 quarters.
  • Bridger Management's Acorda Therapeutics position peaked at $37.8M in Q2 2014.
  • 190 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q1 2015.

Based on Bridger Management's 13F filing for Q1 2015, filed 15 May 2015.